SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000927016-01-503058
Filing Date
2001-10-05
Accepted
2001-10-05 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A AMENDMENT 2 dsc13da.txt SC 13D/A 11520
  Complete submission text file 0000927016-01-503058.txt   12960
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
RIBOZYME PHARMACEUTICALS INC (Subject) CIK: 0000892112 (see all company filings)

IRS No.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47149 | Film No.: 1752854
SIC: 2834 Pharmaceutical Preparations

Mailing Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
Business Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (Filed by) CIK: 0000942257 (see all company filings)